The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 20, 2021

Filed:

May. 23, 2018
Applicant:

City of Hope, Duarte, CA (US);

Inventors:

Sanjay Awasthi, Lubbock, TX (US);

Sushma Yadav, Duarte, CA (US);

Ismail Al Abdullah, Duarte, CA (US);

Fouad Kandeel, Duarte, CA (US);

Brian McFadden, Duarte, CA (US);

Indu Nair, Duarte, CA (US);

Sharad S. Singhal, Duarte, CA (US);

Assignee:

CITY OF HOPE, Duarte, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/39 (2015.01); C12N 5/071 (2010.01); A61K 38/45 (2006.01); C12N 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 35/39 (2013.01); A61K 38/45 (2013.01); C12N 5/0676 (2013.01); C12N 9/1088 (2013.01); C12Y 205/01018 (2013.01); C12N 2501/72 (2013.01);
Abstract

The present disclosure provides novel methods for increasing β-cell viability in islets by delivering RLIP76 polypeptides or GSTA4 polypeptides, or a combination thereof; or RLIP76 polynucleotides or GSTA4 polynucleotides, or a combination thereof, to the islets. The disclosure also provides novel methods for treating a disease or condition in a subject, such as type 1 diabetes mellitus, by delivering RLIP76 polypeptides or GSTA4 polypeptides, or a combination thereof; or RLIP76 polynucleotides or GSTA4 polynucleotides, or a combination thereof, to islets and transplanting the islets into the subject to treat the disease or condition. Kits and compositions including RLIP76 polypeptides or GSTA4 polypeptides, or a combination thereof; or RLIP76 polynucleotides or GSTA4 polynucleotides, or a combination thereof, are also provided to increase β-cell viability.


Find Patent Forward Citations

Loading…